May 3 2019 6:32pm

Mifegymiso cost analysis to be considered in Sask. universal coverage review

A recent business case for universal coverage of Mifegymiso will be considered in a Saskatchewan government decision. Ryan Kessler reports.

Responsive site?

Video Home